Sven Riethmueller is the inaugural Director of the Entrepreneurship & Innovation Clinic at Yale Law School and a Visiting Clinical Associate Professor of Law at Yale Law School. Prior to founding the Entrepreneurship & Innovation Clinic, Professor Riethmueller was in private practice, including as a law firm partner at a national law firm and an international law firm. He has practiced law for more than 20 years, including in Boston, New York, London, Frankfurt, and Las Vegas. Professor Riethmueller has also served in in-house positions, including as the global general counsel and a member of the senior management of a publicly traded life sciences company. He holds a Juris Doctor degree from Columbia University School of Law and a Bachelor of the Arts degree from Dartmouth College.
Until the end of June 2018, Professor Riethmueller was a partner in the Corporate and Securities Practice Group and Health Sciences Department of Pepper Hamilton LLP, resident in its Boston office. Professor Riethmueller was previously a partner at Foley & Lardner LLP in its Boston office.
Professor Riethmueller’s private practice focused on U.S. and European domestic and cross-border technology and business transactions for clients in the life sciences, technology, and other innovative industries. He counseled clients in U.S. and cross-border strategic intellectual property and technology licenses, acquisitions and divestitures, complex partnering, joint venture and collaboration agreements, strategic investments and financings, corporate governance matters, mergers and acquisitions, and other business transactions. A key aspect of his private practice was the commercialization of intellectual property. Professor Riethmueller also served as outside general counsel to U.S. and European companies and represented them in various commercial matters as well as in business and intellectual property disputes and their resolution.
Professor Riethmueller also practiced law as an associate at the law firms Sullivan & Cromwell and Cleary, Gottlieb, Steen & Hamilton in New York, London, and Frankfurt in the areas of cross-border corporate finance and mergers and acquisitions, and advised on some of the largest European securities offerings. In addition, he practiced as a commercial litigator at a leading law firm in the southwestern United States.
Professor Riethmueller also served as vice president and general counsel to LION Bioscience, a publicly-traded global solutions provider for the life sciences industry, and was senior vice president and general counsel with Molecular Health, a private equity-backed precision medicine company.
Professor Riethmueller received his A.B. from Dartmouth College and his J.D. from Columbia University School of Law.